Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D J HobanR N Jones

Abstract

The in vitro activities of numerous antimicrobials against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis from patients with bloodstream and respiratory tract infections in the United States, Canada, Europe, Latin America, and the Asia-Pacific region were studied in the SENTRY Antimicrobial Surveillance Program. Penicillin resistance (minimum inhibitory concentration, > or =2 microg/mL) was noted in all 5 geographic regions, and a high and increasing rate of macrolide resistance among S. pneumoniae isolates was observed. Elevated rates of resistance to clindamycin, trimethoprim-sulfamethoxazole, chloramphenicol, and tetracycline were seen. beta-Lactamase-mediated resistance in H. influenzae to amoxicillin and variable trimethoprim-sulfamethoxazole resistance by region were documented. Resistance to several drugs continues to emerge among pneumococci worldwide, but more stable resistance patterns have been noted for H. influenzae and M. catarrhalis. Continued surveillance of this pathogen group appears to be prudent.

References

Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H J KoornhofK Klugman
Jul 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P GeslinJ F Acar
Apr 1, 1990·Clinical Microbiology Reviews·K P Klugman
May 1, 1995·Antimicrobial Agents and Chemotherapy·R YoshidaH Koga
Jul 1, 1994·Diagnostic Microbiology and Infectious Disease·G Privitera
Dec 1, 1995·Antimicrobial Agents and Chemotherapy·K M KamM M Cheung
Oct 1, 1996·Diagnostic Microbiology and Infectious Disease·V D ShortridgeS K Tanaka
Jun 23, 1998·Diagnostic Microbiology and Infectious Disease·R N Jones, M A Pfaller
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G V DoernR N Jones
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V D ShortridgeR K Flamm
Dec 22, 1999·Emerging Infectious Diseases·G V DoernE Wingert

❮ Previous
Next ❯

Citations

Dec 2, 2004·Indian Journal of Pediatrics·Feyzullah CetinkayaGunsel Kutluk
Nov 2, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S KanavakiG Samonis
Nov 8, 2007·Current Allergy and Asthma Reports·Ricardo Tan, Sheldon Spector
Jan 1, 2003·Current Therapeutic Research, Clinical and Experimental·Adriano ArguedasConstance D Rothermel
Sep 12, 2013·European Journal of Medicinal Chemistry·Yanpeng XuPingsheng Lei
Jan 21, 2004·International Journal of Antimicrobial Agents·Matsuhisa InoueDavid Felmingham
Sep 27, 2003·International Journal of Antimicrobial Agents·Roman PallaresUNKNOWN Spanish Pneumococcal Infection Study Network
Jan 9, 2003·Obstetrics and Gynecology·Shannon D ManningMark D Pearlman
Dec 20, 2003·Lancet·Thomas M File
May 14, 2003·Journal of Neuroimmunology·Petra J G ZwijnenburgA Marceline van Furth
Apr 23, 2003·Vaccine·Katherine L O'Brien, Ron Dagan
Feb 23, 2002·Diagnostic Microbiology and Infectious Disease·Ronald N JonesTamara R Anderegg
Jun 8, 2002·Diagnostic Microbiology and Infectious Disease·Charles H BallowUNKNOWN North American ZAPS Research Group
Dec 21, 2002·Diagnostic Microbiology and Infectious Disease·Ronald N Jones
Oct 12, 2002·Diagnostic Microbiology and Infectious Disease·Ronald N Jones, Lionel A Mandell
Sep 26, 2002·International Journal of Antimicrobial Agents·Elizabeth L PalavecinoM R Jacobs
May 3, 2003·International Journal of Antimicrobial Agents·D J HobanUNKNOWN Surveillance Study Research Group
Aug 21, 2003·International Journal of Antimicrobial Agents·J M BlondeauL Blanco
Sep 27, 2002·Current Opinion in Pharmacology·Angela M Nilius, Zhenkun Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.